# GABAPENTIN
> **ANDA209855** · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-05-29
## Drug
- **FDA Application Number:** ANDA209855
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN
- **Generic name:** Gabapentin
- **Active ingredients:** GABAPENTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** IPCA LABS LTD
- **First approval:** 2024-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209855)
---
*MORVS · CC0 1.0*